A Phase I/II Open Label Study of IV Busulfan (Busulfex) in Multiple Myeloma Patients 65 Years of Age or Older, or With Renal Insufficiency Undergoing Autologous Transplantation.
Phase of Trial: Phase I/II
Latest Information Update: 26 May 2017
At a glance
- Drugs Busulfan (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 27 Feb 2012 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.